- Home
- SOC vs DNLI Comparison
SOC vs DNLI Comparison
Compare SOC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOC
- DNLI
- Stock Information
- Founded
- SOC 2020
- DNLI 2013
- Country
- SOC United States
- DNLI United States
- Employees
- SOC N/A
- DNLI N/A
- Industry
- SOC
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOC
- DNLI Health Care
- Exchange
- SOC Nasdaq
- DNLI Nasdaq
- Market Cap
- SOC 2.0B
- DNLI 2.1B
- IPO Year
- SOC N/A
- DNLI 2017
- Fundamental
- Price
- SOC $19.10
- DNLI $15.42
- Analyst Decision
- SOC Buy
- DNLI Strong Buy
- Analyst Count
- SOC 3
- DNLI 15
- Target Price
- SOC $30.00
- DNLI $33.50
- AVG Volume (30 Days)
- SOC 5.9M
- DNLI 2.1M
- Earning Date
- SOC 11-13-2025
- DNLI 11-05-2025
- Dividend Yield
- SOC N/A
- DNLI N/A
- EPS Growth
- SOC N/A
- DNLI N/A
- EPS
- SOC N/A
- DNLI N/A
- Revenue
- SOC N/A
- DNLI N/A
- Revenue This Year
- SOC N/A
- DNLI N/A
- Revenue Next Year
- SOC $184.34
- DNLI $95,463.19
- P/E Ratio
- SOC N/A
- DNLI N/A
- Revenue Growth
- SOC N/A
- DNLI N/A
- 52 Week Low
- SOC $16.26
- DNLI $10.57
- 52 Week High
- SOC $35.00
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- SOC 38.61
- DNLI 62.72
- Support Level
- SOC $17.25
- DNLI $12.58
- Resistance Level
- SOC $20.32
- DNLI $15.75
- Average True Range (ATR)
- SOC 1.83
- DNLI 0.68
- MACD
- SOC -0.21
- DNLI 0.24
- Stochastic Oscillator
- SOC 23.99
- DNLI 89.59
About SOC Sable Offshore Corp. Common Stock
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.